Mark Jean Gnoth
31Patents
6h-index
80Co-inventors
68Inventor score
Filing activity: Mar 30, 2005 → Mar 21, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9284319B2 | Heterocyclyl aminoimidazopyridazines | Human Necessities | 24 | Active |
| US9320737B2 | Substituted imidazopyridazines | Chemistry; Metallurgy | 24 | Active |
| US9730929B2 | Substituted aminoimidazopyridazines | Chemistry; Metallurgy | 21 | Active |
| US8119663B2 | Heteroaryl-substituted piperidines | Chemistry; Metallurgy | 16 | Active |
| US8273752B2 | Substituted imidazopyrimidines and triazolopyrimidines | Human Necessities | 10 | Active |
| US9434731B2 | Imidazo-, pyrazolopyrazines and imidazotriazines and their use | Chemistry; Metallurgy | 7 | Active |
| US9029406B2 | N-carboxyalkylauristatins and use thereof | Human Necessities | 5 | Active |
| US8198267B2 | Substituted oxazolidinones and their use | Human Necessities | 4 | Active |
| US9643953B2 | Substituted benzylpyrazoles | Chemistry; Metallurgy | 4 | Active |
| US9499547B2 | Amino-substituted imidazopyridazines | Human Necessities | 3 | Active |
| US8084469B2 | Substituted piperidines | Chemistry; Metallurgy | 2 | Active |
| US8202862B2 | Substituted piperidines | Chemistry; Metallurgy | 2 | Active |
| US8916557B2 | Substituted 4-Aryl-N-phenyl-1,3,5-triazin-2-amines | Chemistry; Metallurgy | 2 | Active |
| US10266548B2 | Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases | Chemistry; Metallurgy | 1 | Active |
| US9669034B2 | 4-aryl-N-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group | Chemistry; Metallurgy | 1 | Active |
| US8383822B2 | Substituted oxazolidinones and their use | Human Necessities | 1 | Active |
| US8329716B2 | Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors | Human Necessities | 1 | Active |
| US9416125B2 | Substituted cycloalkenopyrazoles as BUB1 inhibitors for the treatment of cancer | General | 0 | Revoked |
| US9265763B2 | Substituted benzylindazoles for use as Bub1 kinase inhibitors in the treatment of hyperproliferative diseases | General | 0 | Revoked |
| US8436003B2 | Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines | Human Necessities | 0 | Active |
| US8846934B2 | Substituted oxazolidinones and their use | Human Necessities | 0 | Active |
| US8476267B2 | Imidazo-, pyrazolopyrazines and imidazotriazines and their use | Chemistry; Metallurgy | 0 | Active |
| US8487111B2 | Substituted oxazolidinones and their use | Human Necessities | 0 | Active |
| US9260412B2 | Substituted benzylpyrazoles | General | 0 | Revoked |
| US9422268B2 | Substituted benzylpyrazoles | General | 0 | Revoked |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.